Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**RNA, U6atac small nuclear 30, pseudogene** (RNU6ATAC30P) is a non-coding RNA pseudogene that structurally resembles the functional U6atac small nuclear RNA genes, which are components of the minor spliceosome complex involved in pre-mRNA splicing[1][3]. As a pseudogene, RNU6ATAC30P is characterized by sequence homology to the parental U6atac snRNA gene but is typically non-functional due to sequence alterations or truncations that prevent normal RNA activity[1][3]. Pseudogenes like RNU6ATAC30P are primarily considered genomic relics generated via retrotransposition, often mediated by LINE-1 (L1) retrotransposons, and usually do not produce functional RNA or protein products[3]. However, some pseudogenes are known to play regulatory roles (e.g., as microRNA decoys), but there is no evidence that RNU6ATAC30P is involved in such processes or in human disease[2][3][1]. Therefore, this gene is not considered a therapeutic target, nor is it directly associated with any known pathological process.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6atac small nuclear 30, pseudogene (RNU6ATAC30P).